Serum Institute of India has created more than 10 crore doses of Covishield as of June
As India cranks up the pace of its immunization push in the face of a likely third wave of the virus infection, the Serum Institute of India has generated over 10 crore doses of its Covid-19 vaccine Covishield so far in June.
The current phase of universalization of Covid-19 immunization, which began on June 21, has accelerated India’s Covid-19 inoculation push, with an average of 69 lakh vaccine doses provided every day in the last six days.
India provided 64.25 lakh vaccine doses in a single day, bringing the total number of shots given under the nationwide vaccination effort to 32.17 crores, according to figures released at 7 a.m. on Sunday.
The Pune-based Serum Institute of India has so far delivered 45 batches of Covishield to the Central Drugs Laboratory in Kasauli for release in June, according to information provided to the Drugs Controller General of India (DCGI).
Prakash Kumar Singh, the company’s Director of Government and Regulatory Affairs, informed Union Home Minister Amit Shah in May that Covishield production would be increased to 10 crore doses in June.
“We are dedicated to increasing the production capacity of our Covishield vaccine and have been working around the clock despite the numerous hurdles we have faced as a result of the Covid-19 outbreak.”
“We are glad to inform you that in the month of June, we will be able to make and distribute nine to ten crore doses of our Covishield vaccine to our country, as opposed to our current production capacity of 6.5 crore doses in May,” Singh stated in a letter to Shah.
According to the Health Ministry, the nationwide vaccination effort has been boosted by the availability of additional vaccines, advanced visibility of vaccine availability to states and union territories, allowing them to plan ahead of time, and streamlining the vaccine supply chain.
Vaccine doses are distributed free of charge by the Centre under the updated guidelines and are allocated to states and Union Territories based on criteria such as population, disease burden, and immunization progress. 75% of the vaccines produced in the country are procured by the Centre.
Free vaccine shots are available to everyone over the age of 18.
Following demands for decentralisation of the procedure, the Centre previously authorised states and private hospitals to buy 50% of the vaccines. Following complaints from numerous states about financing issues, Prime Minister Narendra Modi proposed new immunisation guidelines.
Domestic manufacturers are given the option of providing vaccinations directly to private hospitals in order to incentivize production and stimulate innovative vaccines. Under the current restrictions, this is limited to 25% of their monthly production.